AR021808A1 - Composicion nueva - Google Patents

Composicion nueva

Info

Publication number
AR021808A1
AR021808A1 ARP990104626A ARP990104626A AR021808A1 AR 021808 A1 AR021808 A1 AR 021808A1 AR P990104626 A ARP990104626 A AR P990104626A AR P990104626 A ARP990104626 A AR P990104626A AR 021808 A1 AR021808 A1 AR 021808A1
Authority
AR
Argentina
Prior art keywords
composition
component
disorders
new composition
diclobutylamino
Prior art date
Application number
ARP990104626A
Other languages
English (en)
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR021808A1 publication Critical patent/AR021808A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990104626A 1998-09-16 1999-09-15 Composicion nueva AR021808A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803156A SE9803156D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
AR021808A1 true AR021808A1 (es) 2002-08-07

Family

ID=20412627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104626A AR021808A1 (es) 1998-09-16 1999-09-15 Composicion nueva

Country Status (21)

Country Link
EP (1) EP1128825A1 (no)
JP (1) JP2002524508A (no)
KR (1) KR20010099647A (no)
CN (1) CN1317964A (no)
AR (1) AR021808A1 (no)
AU (1) AU6378099A (no)
BR (1) BR9913748A (no)
CA (1) CA2342341A1 (no)
CZ (1) CZ2001961A3 (no)
EE (1) EE200100157A (no)
HU (1) HUP0103544A3 (no)
ID (1) ID28785A (no)
IL (1) IL141519A0 (no)
IS (1) IS5879A (no)
NO (1) NO20011312L (no)
PL (1) PL346763A1 (no)
SE (1) SE9803156D0 (no)
SK (1) SK3262001A3 (no)
TR (1) TR200100779T2 (no)
WO (1) WO2000015218A1 (no)
ZA (1) ZA200101946B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9543601A (en) * 2000-10-13 2002-04-22 Neurosearch As Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
JPWO2006093192A1 (ja) * 2005-03-04 2008-08-07 国立大学法人 東京医科歯科大学 覚醒剤精神病及び統合失調症の再発防止治療薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
IL141519A0 (en) 2002-03-10
EE200100157A (et) 2002-08-15
NO20011312D0 (no) 2001-03-15
IS5879A (is) 2001-03-07
HUP0103544A2 (hu) 2002-05-29
ID28785A (id) 2001-07-05
WO2000015218A1 (en) 2000-03-23
TR200100779T2 (tr) 2001-10-22
PL346763A1 (en) 2002-02-25
EP1128825A1 (en) 2001-09-05
SK3262001A3 (en) 2001-08-06
KR20010099647A (ko) 2001-11-09
ZA200101946B (en) 2002-06-10
AU6378099A (en) 2000-04-03
CA2342341A1 (en) 2000-03-23
NO20011312L (no) 2001-05-16
SE9803156D0 (sv) 1998-09-16
BR9913748A (pt) 2001-07-10
CN1317964A (zh) 2001-10-17
HUP0103544A3 (en) 2003-12-29
JP2002524508A (ja) 2002-08-06
CZ2001961A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
SE9501567D0 (sv) A new combination
AR015448A1 (es) COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN
MY125414A (en) Aminopropylphosphinic acids
GT200100153A (es) Compuestos de 1,4-dihidropiridina como antagonistas de bradiquinina.
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
BRPI0414428A (pt) composições farmacêuticas
PT1238676E (pt) Combinacao de um inibidor de reabsorcao de serotonina com um antipsicotico para utilizacao na depressao na patologia obsessiva compulsiva e na psicose
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
SE0102055D0 (sv) New Compounds
BR0308133A (pt) Forma polimórfica cristalina de cloridrato de irinotecan
AR013503A1 (es) Una combinacion de un inhibidor de la monoamina oxidasa y un antagonista o agonista parcial selectivo de h5-ht(1b), formulacion farmaceutica, usos ymetodo de preparacion
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
BR9810773A (pt) Uso de um ingrediente anestésico local de ação prolongada, composição farmacêutica, uso de um anestésico local, e, kit
PA8514901A1 (es) Metabolitos agonistas/antagonistas de estrogeno
UA87980C2 (ru) Композиция для улучшения познания и памяти
AR035818A1 (es) Fenil-heterociclil-eteres con actividad como inhibidores selectivos de recaptacion de serotonina, composiciones farmaceuticas y su uso en la fabricacion de medicamentos
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
AR021808A1 (es) Composicion nueva
SE9804126D0 (sv) New pharmaceutical composition
BRPI0411174A (pt) combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão
AR023657A1 (es) Composicion, usos de la misma, formulacion farmaceutica, proceso para la preparacion de la composicion y kit
AR033779A1 (es) Compuestos utiles en la enfermedad de reflujo
BR0009194A (pt) Composição do resorcinol
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
BR0210063A (pt) Composição estável e uso da mesma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal